Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy

Neuroscience

Volumn 154, Issue 2, 2008, Pages 701-709

  Meyer, U ^a   Engler, A ^a   Weber, L ^a   Schedlowski, M ^b   Feldon, J ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

cytokines; dopamine; infection; PolyI:C; pregnancy; schizophrenia

Indexed keywords

CYTOKINE; DOPAMINE TRANSPORTER; FIBROBLAST GROWTH FACTOR 8; NUCLEAR RECEPTOR RELATED FACTOR 1; POLYINOSINIC POLYCYTIDYLIC ACID; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FEMALE; FETUS DEVELOPMENT; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VIVO STUDY; MALE; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; ANTIGENS; CYTOKINES; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; FETAL DEVELOPMENT; FETUS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; POLY I-C; PREGNANCY; PREGNANCY, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TYROSINE 3-MONOOXYGENASE;

EID: 46549087172     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.04.031     Document Type: Article

References (46)

1. Aoto K., Nishimura T., Eto K., and Motoyama J. Mouse GLI3 regulates Fgf8 expression and apoptosis in the developing neural tube, face, and limb bud. Dev Biol 251 (2002) 320-332
2. Arndt T.L., Stodgell C.J., and Rodier P.M. The teratology of autism. Int J Dev Neurosci 23 (2005) 189-199
3. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., and Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 11 (2006) 47-55
4. Bayer S.A., Wills K.V., Triarhou L.C., and Ghetti B. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp Brain Res 105 (1995) 191-199
5. Borrell J., Vela J.M., Arévalo-Martin A., Molina-Holgado E., and Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats: Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26 (2002) 204-221
6. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 32 (2006) 200-202
7. Brown A.S., and Susser E.S. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 8 (2002) 51-57
8. Burbach J.P., and Smidt M.P. Molecular programming of stem cells into mesodiencephalic dopaminergic neurons. Trends Neurosci 29 (2006) 601-603
9. Cunningham C., Campion S., Teeling J., Felton L., and Perry V.H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun 21 (2007) 490-502
10. Fatemi S.H. Neuropsychiatric disorders and infection (2005), Martin Dunitz-Taylor & Francis Group, London
11. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 22 (2002) 25-33
12. Fatemi S.H., Emamian E.S., Kist D., Sidwell R.W., Nakajima K., Akhter P., et al. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 4 (1999) 145-154
13. Fortier M.E., Joober R., Luheshi G.N., and Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 38 (2004) 335-345
14. Fortier M.E., Kent S., Ashdown H., Poole S., Boksa P., and Luheshi G.N. The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 287 (2004) R759-R766
15. Fortier M.E., Luheshi G.N., and Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 181 (2007) 270-277
16. Gilmore J.H., and Jarskog L.F. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 24 (1997) 365-367
17. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96 (1988) 857-881
18. Howard C.V., and Reed M.G. Unbiased stereology (2005), Garland Science/BIOS Scientific Publishers, New York
19. Hynes M., and Rosenthal A. Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr Opin Neurobiol 9 (1999) 26-36
20. Kaufman M.H. The atlas of mouse development (2003), Academic Press, London
21. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25 (2001) 402-408
22. Martinat C., Bacci J.J., Leete T., Kim J., Vanti W.B., Newman A.H., et al. Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci U S A 103 (2006) 2874-2879
23. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29 (2005) 913-947
24. Meyer U., Murray P.J., Urwyler A., Yee B.K., Schedlowski M., and Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13 (2008) 208-221
25. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., and Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33 (2008) 441-456
26. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26 (2006) 4752-4762
27. Meyer U., Yee B.K., and Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist 13 (2007) 241-256
28. Molinoff P.B., and Axelrod J. Biochemistry of catecholamines. Annu Rev Biochem 40 (1971) 465-500
29. Nawa H., and Takei N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56 (2006) 2-13
30. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., and Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59 (2006) 546-554
31. Patterson P.H. Neuroscience. Maternal effects on schizophrenia risk. Science 318 (2007) 576-577
32. Perrone-Capano C., Tino A., and di Porzio U. Target cells modulate dopamine transporter gene expression during brain development. Neuroreport 5 (1994) 1145-1148
33. Roussa E., and Krieglstein K. Induction and specification of midbrain dopaminergic cells: focus on SHH, FGF8, and TGF-beta. Cell Tissue Res 318 (2004) 23-33
34. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci U S A 95 (1998) 4013-4018
35. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23 (2003) 297-302
36. Smidt M.P., and Burbach J.P. How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci 8 (2007) 21-32
37. Smidt M.P., van Schaick H.S., Lanctôt C., Tremblay J.J., Cox J.J., van der Kleij A.A., et al. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc Natl Acad Sci U S A 94 (1997) 13305-13310
38. Smith S.E., Li J., Garbett K., Mirnics K., and Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27 (2007) 10695-10702
39. Smits S.M., Ponnio T., Conneely O.M., Burbach J.P., and Smidt M.P. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur J Neurosci 18 (2003) 1731-1738
40. Solberg Y., Silverman W.F., and Pollack Y. Prenatal ontogeny of tyrosine hydroxylase gene expression in the rat ventral mesencephalon. Dev Brain Res 73 (1993) 91-97
41. Vignali D.A. Multiplexed particle-based flow cytometric assays. J Immunol Methods 243 (2000) 243-255
42. Ye W., Shimamura K., Rubenstein J.L., Hynes M.A., and Rosenthal A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93 (1998) 755-766
43. Zetterström R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., and Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276 (1997) 248-250
44. Zorrilla E.P. Multiparous species present problems (and possibilities) to developmentalists. Dev Psychobiol 30 (1997) 141-150
45. Zuckerman L., Rehavi M., Nachman R., and Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28 (2003) 1778-1789
46. Zuckerman L., and Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39 (2005) 311-323